The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Author(s):
Papapoulos, S.; Lippuner, K.; Roux, C.; Lin, C.J.F.; Kendler, D.L.; Lewiecki, E.M.; Brandi, M.L.; Czerwinski, E.; Franek, E.; Lakatos, P.; Mautalen, C.; Minisola, S.; Reginster, J.Y.; Jensen, S.; Daizadeh, N.S.; Wang, A.; Gavin, M.; Libanati, C.; Wagman, R.B.; Bone, H.G.
Published
2015
Publication type
Article / Letter to editor
Bone mineral densityClinical trialDenosumabFractureOsteoporosisSafety
Date issued
2015-12-31
Language
English
Is part of
Osteoporosis International (2015), Vol. 26, no. 12, p. 2773-2783
hdl
1887/101286
doi
10.1007/s00198-015-3234-7